arrow
K

Krystle N. Agans

university of texas medical branch
H指数:39
被引数:4,377

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Analysis of Recombinant Cedar Virus Infection and Cross-Protection Against Related Henipaviruses in African Green Monkeys

重组雪松病毒感染及其对相关亨尼帕病毒交叉保护作用的分析在非洲绿猴中的研究

Viruses
IF3.5
2026-02-280
OAAI
Experimental challenge of African green monkeys with contemporary Hendra virus isolates produces divergent clinical disease

使用当代Hendra病毒分离株对非洲绿猴进行实验性挑战会产生不同的临床疾病。

2025-08-220
OAAI
Lassa fever in African green monkeys: Clinical disease and fatal outcome are associated with systemic viral dissemination and inflammation

拉沙热在非洲绿猴中:临床疾病和致命结局与系统性病毒扩散和炎症相关

2025-08-050
OAAI
Remdesivir, mAb114, REGN-EB3, and ZMapp partially rescue nonhuman primates infected with a low passage Kikwit variant of Ebola virus

瑞德西韦、mAb114、REGN-EB3 和 ZMapp 对感染了低代次基奎特变种埃博拉病毒的灵长类动物具有部分拯救效果。

2025-04-230
OA
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials

一种基于复制性-vesicular stomatitis virus的拉沙病毒疫苗候选物的临床前开发已进入人体临床试验阶段。

2025-04-010
OAAI
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates

靶向Nipah病毒融合糖蛋白的交叉反应性mAb的治疗性给药可保护非人类灵长类动物

2024-04-034
PRE
The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms

治疗性单克隆抗体Bamlanivimab不会通过FcR介导的机制增强SARS-CoV-2感染

2023-11-302
OAAI
A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus

人类单克隆抗体组合可挽救非人类灵长类动物免于拉萨病毒主要谱系引起的晚期疾病

2023-08-179
OAAI
Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal Antibody

使用非岩藻糖基化单克隆抗体长期预防非人类灵长类动物的雾化马尔堡病毒

2023-07-201
OA